Its US subsidiary, Lupin Pharmaceuticals Inc has launched the authorised generic for GD Searle LLC's (a subsidiary of Pfizer) Celebrex capsules of strength of 50 mg, 100 mg, 200 mg and 400 mg, the ...
PITTSBURGH, Dec. 10, 2014 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL) today announced the U.S. launch of its Celecoxib Capsules, 50 mg, 100 mg, 200 mg, and 400 mg, one of the first available generic ...
Strides Pharma Global, Singapore, has received approval for celecoxib capsules, 100 mg, 200 mg and 400 mg from the Food and Drug Administration. The product is the generic of Upjohn’s Celebrex. The ...
The US Food and Drug Administration (FDA) today approved the first generic versions of the anti-inflammatory drug celecoxib (Celebrex, Pfizer) in the wake of legal wrangling between the brand-name ...
Mumbai, Baltimore, December 11, 2014: Pharma Major Lupin Limited announced today that its US subsidiary, Lupin Pharmaceuticals Inc. (collectively Lupin) has launched the authorized generic for G.D.
Lupin’s Celecoxib capsules are the AB-rated generic equivalents of GD Searle LLC ‘s Celebrex capsules Lupin has received final approval for its Celecoxib capsules, 50 mg from the US Food and Drugs ...
The FDA has granted approval for the first generic versions of Celebrex (celecoxib; Pfizer) capsules. Teva has been approved to market Celecoxib Capsules in 50mg, 100mg, 200mg, and 400mg strengths.
Strides Pharma has said that its step-down wholly owned subsidiary, Strides Pharma Global Pte., Singapore, has received approval for celecoxib capsules, 100 mg, 200 mg, and 400 mg, from the United ...
PITTSBURGH, Dec. 10, 2014 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL) today announced the U.S. launch of its Celecoxib Capsules, 50 mg, 100 mg, 200 mg, and 400 mg, one of the first available generic ...
Lupin Ltd has informed BSE regarding a Press Release dated November 03, 2014, titled "Lupin Receives FDA Approval for Generic Celebrex® Capsules" Lupin has received final approval for its Celecoxib ...
Pharma Major Lupin Limited announced today that its US subsidiary, Lupin Pharmaceuticals Inc. (collectively Lupin) has launched the authorized generic for G.D. Searle LLC's (a subsidiary of Pfizer Inc ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback